mtvc2 Profile Banner
Vincent Clay Profile
Vincent Clay

@mtvc2

Followers
830
Following
3K
Media
384
Statuses
4K

EU stuff, healthcare, urban cycling, occasional topical music. And climate, because we’re in a huge mess. Work @novonordisk. Views personal.

Brussels
Joined January 2013
Don't wanna be here? Send us removal request.
@mtvc2
Vincent Clay
1 year
Enough squabbling between Paris and Rome. #EmilyinSchengen is the solution.
@Variety
Variety
1 year
Emmanuel Macron says he will “fight hard” for “Emily in Paris” to return to Paris: “We will ask them to remain in Paris! ‘Emily in Paris’ in Rome doesn’t make sense.” https://t.co/n9uMJ0ggDo
0
1
5
@Bruxselair
Bruxsel'AIR
1 year
We tried to stay out of politics field. But seen next Sunday milestone, it's time for a bit of name and shame. Last Friday, our representative showed how much they care about Brussels poeple's health. This sunday you will be expressing your views by voting too. Keep it in mind.
14
31
78
@vestager
Margrethe Vestager
1 year
🇪🇺 & 🇺🇸 have strong biotechs. They do amazing things. Like slowing the progression of deseases that we struggle to understand. Europe must progress on 2 things: 👉 ⬆️ access to venture capital for 🇪🇺 startups 👉 ⬇️ reduce fragmentation of the single market 💪 @LabCentral
9
9
59
@mtvc2
Vincent Clay
1 year
Social media platform owner, with access to extensive user experience data and insights, personally encounters the first that thing that most people learn on social media. Or even email. Or 🐌 a letter.
@elonmusk
Elon Musk
1 year
Turns out that jokes are WAY less funny if people don’t know the context and the delivery is plain text
0
0
0
@mtvc2
Vincent Clay
1 year
World’s richest person struggles with news that he is not also world’s funniest person. #problems
@elonmusk
Elon Musk
1 year
Well, one lesson I’ve learned is that just because I say something to a group and they laugh doesn’t mean it’s going to be all that hilarious as a post on 𝕏
0
0
1
@teamnovonordisk
Team Novo Nordisk
2 years
#BaloiseBelgiumTour🇧🇪 "I’m really comfortable with this type of final now, I feel confident moving with the sway of the bunch and the last few kilometers I managed to avoid some of the chaos and a late crash to time my sprint pretty nicely and achieve the goal of getting into
0
1
18
@teamnovonordisk
Team Novo Nordisk
2 years
#BaloiseBelgiumTour🇧🇪 Fantastic result from Matyas Kopecky and the boys with 10th on the final stage! 👊 second top ten of the race! #DrivingChange #Diabetes
0
2
26
@teamnovonordisk
Team Novo Nordisk
2 years
#BaloiseBelgiumTour🇧🇪 10th for Matyas Kopecky on a tough finish in Knokke-Heist! Caught a bit of wind in the last 500m but made it back into the sprint for yet another top 10 👊 #DrivingChange #Diabetes
0
2
15
@teamnovonordisk
Team Novo Nordisk
2 years
#BaloiseBelgiumTour🇧🇪 Still in Belgium, but now it's stage race time! This is our lineup for the @belgium_tour, kicking off tomorrow with an individual time trial 🙌 Stay tuned! #DrivingChange #Diabetes
0
1
16
@teamnovonordisk
Team Novo Nordisk
2 years
#BaloiseBelgiumTour🇧🇪 "The competition is usually fiercely strong at the @belgium_tour and this year will be no different, so it will be important to be at our best in terms of communication, performance and how we conduct ourselves in the eyes of the global diabetes community
0
1
16
@ftbrussels
FT Europe
2 years
EU rules drive pharma backers to the US, says Irish investment chief
ft.com
Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan
0
1
1
@mtvc2
Vincent Clay
2 years
“When looking for new treatments, I’m looking to work with entrepreneurs - and those entrepreneurs need an environment with good funding, good education, and good IP.” Karin Conde-Knape, head of drug discovery @novonordisk. #Horizon40 #SB20years @scibus
1
0
3
@teamnovonordisk
Team Novo Nordisk
2 years
Without research and innovation, there's no progress. Our 2024 kit cheers for scientists all over the world as they continue to break boundaries and change lives. Imagine the potential that future innovation holds. #DrivingChange #Diabetes
1
7
27
@Vitavox_
Vitavox Institute
2 years
Europe confronts significant external threats and concerns regarding its competitiveness. Among the most resilient assets within the EU is the pharmaceutical sector. Lars Fruergaard Jorgensen CEO of Novo Nordisk And @EFPIA president #EHS2023
0
1
4
@EFPIA
EFPIA
2 years
Europe is faced with major external threats & worries about its competitiveness. The pharmaceutical sector is one of 🇪🇺 most resilient assets. Future leadership in biotechnology is something Europe needs to pursue – the rest of the world is not standing still #WeWontRest #EHS2023
0
4
3
@ebsummiteurope
European Business Summits
2 years
“It’s important to acknowledge that our industry is global & it’s built on knowledge 👉We have to ensure that Europeans have access to innovation.” @EFPIA @Novonordisk @LarsFruergaard at #ehs2023
0
2
3
@ebsummiteurope
European Business Summits
2 years
How can we make the healthcare sector stronger in the future? 👇 @EFPIA @Novonordisk @LarsFruergaard at #ehs2023: “By having close dialogue, understanding how the market works, and acknowledging that the industry is committed to ensuring that patients have access to medicine.”
0
1
0
@novonordisk
Novo Nordisk
2 years
#PRESS: Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark
8
20
165
@EFPIA
EFPIA
2 years
📢Join the EFPIA team! We have a number of positions open: 🔵Executive Director International Affairs 🟠Legal Affairs Manager 🟣Healthcare Systems Intern 🟢Public Affairs Intern 🟡Legal Affairs Intern Check our website for more details and apply now: https://t.co/sOHGaTRbNm
0
1
2
@mtvc2
Vincent Clay
2 years
A new study from Copenhagen Economics examines economic impact of the #pharmaceutical sector in #EU, & finds that 80% of total gross value added (GVA) stems from innovative segment https://t.co/vmHf88CZhQ #EUpharmastrategy nb study funded by NN; analysis is responsibility of CE
Tweet card summary image
linkedin.com
Today, the pharmaceutical industry is the industry in the EU with the largest trade surplus, which means that a significant part of the up to 865,000 jobs in the pharmaceutical industry is driven by...
0
1
2